Vantage Consulting Group Inc Abb Vie Inc. Transaction History

Vantage Consulting Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $7,584 - $8,857	49 Added 3.68%	1,379 $236,000
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $37,877 - $43,157	-237 Reduced 15.12%	1,330 $242,000
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $1,238 - $1,394	9 Added 0.58%	1,567 $242,000
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $14,561 - $16,856	-109 Reduced 6.54%	1,558 $232,000
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $8,878 - $11,048	67 Added 4.19%	1,667 $224,000
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $16,485 - $18,985	114 Added 7.67%	1,600 $254,000
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $45,918 - $55,068	-332 Reduced 18.26%	1,486 $240,000
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $19,326 - $22,165	144 Added 8.6%	1,818 $244,000
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $18,578 - $23,619	135 Added 8.77%	1,674 $256,000
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $70,345 - $87,278	-533 Reduced 25.72%	1,539 $249,000
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $22,023 - $27,865	-205 Reduced 9.0%	2,072 $281,000
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $33,941 - $38,528	319 Added 16.29%	2,277 $246,000
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $206,001 - $229,497	1,958 New	1,958 $221,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $70,280 - $77,369	-687 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $55,296 - $74,656	687 New	687 $74,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vantage Consulting Group Inc with notifications on news.